UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES

Similar documents
UPDATE C Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective November 04, 2008 SUMMARY OF CHANGES

UPDATE C Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective November 04, 2008 SUMMARY OF CHANGES

UPDATE E Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective December 23, 2008 SUMMARY OF CHANGES

UPDATE F Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective 30 January, 2009 SUMMARY OF CHANGES

UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES

Product Selection Committee / Comité de sélection des produits

UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/ Comparative Drug Index

UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

SUMMARY OF CHANGES. UPDATE 3 Ontario Drug Benefit Formulary/Comparative Drug Index No. 40 Effective July 12, 2007 TABLE OF CONTENTS.

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/ Comparative Drug Index

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE AZ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 31, 2013 SUMMARY OF CHANGES

UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 57th EDITION OF THE SASKATCHEWAN FORMULARY

Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) Fax / Téléc : (902)

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE AE Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective February 29, 2012 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) Fax / Téléc : (902)

PEI Drug Programs. Issue October, 2006

Updates to the Alberta Drug Benefit List. Effective February 1, 2018

UPDATE 11 Ontario Drug Benefit Formulary/Comparative Drug Index No. 40 Effective April 09, 2008 SUMMARY OF CHANGES

UPDATE AT Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective April 30, 2013 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/ Comparative Drug Index

Product Selection Committee / Comité de sélection des produits

SASKATCHEWAN FORMULARY BULLETIN. Update to the 60th Edition of the Saskatchewan Formulary

UPDATE Z Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 04, 2011 SUMMARY OF CHANGES

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

NB Drug Plans Formulary Update

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

Ontario Drug Benefit Formulary/Comparative Drug Index

NB Drug Plans Formulary Update

Ontario Drug Benefit Formulary/Comparative Drug Index

NBPDP Formulary Update

New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March 2016

Updates to the Alberta Drug Benefit List. Effective November 1, 2018

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN 51st Edition

Archived Content. This content was archived on June 24, 2013.

Ontario Drug Benefit Formulary/Comparative Drug Index

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

BULLETIN # 50. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on March 13, 2006.

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN 52nd Edition

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN 55th EDITION

BULLETIN # 90. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 25, 2017

UPDATE AG Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective April 24, 2012 SUMMARY OF CHANGES

Archived Content. This content was archived on June 24, 2013.

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015

BULLETIN # 80. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 19, 2015

Archived Content. This content was archived on June 24, 2013.

NB Drug Plans Formulary Update

BULLETIN # 74. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 17, 2013

Home Delivery Prescription Program Drug List

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories

Updates to the Alberta Health and Wellness Drug Benefit List

New Exception Status Benefits

Updates to the Alberta Drug Benefit List. Effective August 1, 2014

Home Delivery Prescription Program Drug List

Special Generic Drug Pricing Program

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY

Updates to the Alberta Drug Benefit List. Effective June 1, 2018

NB Drug Plans Formulary Update

Bulletin #36. Manitoba Drug Benefits and Interchangeability Formulary Amendments.

Michigan Department of Community Health Co-pay and Quantity Limitations

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Calgary Long Term Care Formulary

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Michigan Department of Community Health Quantity Limitations

Hundreds of Choices. More Savings Every Day. 8 and $ 12 Generics Also Available. Based on 30-day supply at commonly prescribed doses

BULLETIN # 44. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on September 1, 2004.

BULLETIN # 91. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 20, 2017

Updates to the Alberta Drug Benefit List. Effective July 1, 2017

Transcription:

UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Manufacturer Requested Discontinued Drug(s) 5 Drug Benefit Price(s) 6 Off Formulary Interchangeable Product(s) 7 Consolidated Index for Update A and B 8 Page 1

New Multi-Source Drug(s) DIN BRAND STRENGTH DOSAGE FORM MFR DBP 02301334 Apo-Brimonidine P 0.15% Oph Sol APX 1.1550 (Interchangeable with Alphagan P) Reason for Use Code 171 Clinical Criteria As first line treatment of elevated intraocular pressure in patients who cannot tolerate an ophthalmic beta-blocking agent or where beta-blocking agents are contraindicated; LU Authorization Period: Indefinite. 172 As second line monotherapy or combination therapy in patients who do not have an adequate intraocular pressure lowering response to ophthalmic beta-blocking agents. LU Authorization Period: Indefinite. 387 For use as adjunctive therapy with an ophthalmic beta-blocking agent in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective. LU Authorization Period: Indefinite 02306239 Citalopram-Odan 20mg Tab ODN 0.6250 02306247 Citalopram-Odan 40mg Tab ODN 0.6250 (Interchangeable with Celexa) 02307898 Novo-Oxycodone Acet 5mg & 325mg Tab NOP 0.1285 (Interchangeable with Percocet) Page 2

DIN BRAND STRENGTH DOSAGE FORM MFR DBP 02306212 Ondansetron-Odan 4mg Tab ODN 5.9884 02306220 Ondansetron-Odan 8mg Tab ODN 9.1402 (Interchangeable with Zofran) Reason for Use Code 215 Clinical Criteria For the treatment of emesis in cancer patients receiving highly emetogenic chemotherapy. LU Authorization Period: 1 year. 216 For patients receiving intravenous chemotherapy or radiation therapy who have not experienced adequate control with other available anti-emetics. LU Authorization Period: 1 year. 217 For patients receiving intravenous chemotherapy or radiation therapy who experience intolerable side effects with other anti-emetics. LU Authorization Period: 1 year. 218 For the treatment of emesis in patients receiving radiation therapy which consists of single fraction treatment to the abdominal cavity, hemi-body irradiation and total body irradiation. NOTE: The therapeutic value of Zofran more than 24 hours after the last dose of chemotherapy is unproven. LU Authorization Period: 1 year. 02302616 PMS-Diclofenac 25mg Ent Tab PMS 0.1563 02302624 PMS-Diclofenac 50mg Ent Tab PMS 0.3932 (Interchangeable with Voltaren) 02269430 Sandoz Paroxetine 20mg Tab SDZ 0.7950 02269449 Sandoz Paroxetine 30mg Tab SDZ 0.8450 (Interchangeable with Paxil) Page 3

DIN BRAND STRENGTH DOSAGE FORM MFR DBP 02314177 Sandoz Rabeprazole 10mg Tab SDZ 0.3250 02314185 Sandoz Rabeprazole 20mg Tab SDZ 0.6500 (Interchangeable with Pariet) Page 4

Manufacturer Requested Discontinued Drug(s) Please note that these discontinued products will remain on the formulary until the current stock is depleted. DIN BRAND STRENGTH DOSAGE FORM MFR 00265489 C.E.S. 1.25mg Tab VAL 02097389 Cardizem 60mg Tab BIO 00514217 M.O.S. 5mg/mL O/L VAL 02254751 Sandoz Paroxetine 20mg Tab SDZ 02254778 Sandoz Paroxetine 30mg Tab SDZ 00894710 Terazol 3 80mg Vag Ovule JNO 00268607 Vitamin B6-ICN 25mg Tab VAL Page 5

Drug Benefit Price(s) DIN BRAND STRENGTH DOSAGE FORM MFR DBP 02242987 Diamicron MR 30mg SR Tab SEV 0.1405 02243644 Kaletra 80mg/mL & 20mg/mL O/L ABB 2.1245 02285533 Kaletra 200mg & 50mg Tab ABB 5.4004 02212331 Zantac 150mg Tab GSK 0.1800 02212358 Zantac 300mg Tab GSK 0.3600 Page 6

Off Formulary Interchangeable Product(s) DIN BRAND STRENGTH DOSAGE FORM MFR UNIT COST 02229080 Apo-Ketorolac 10mg Tab APX 0.4550 (Interchangeable with Toradol) 02262983 Supeudol 20mg Tab SDZ 0.5810 (Interchangeable with Oxy.IR) Page 7

CONSOLIDATED INDEX PRODUCT, STRENGTH & DOSAGE FORM DIN MFR UPDATE PAGE NO. Actonel 5mg Tab 02242518 PGP A 11 Actonel 30mg Tab 02239146 PGP A 11 Actonel 35mg Tab 02246896 PGP A 11 Androgel 1% 2.5g Foil Packet 02245345 SPH A 11 Apo-Atenidone 50 & 25mg Tab 02248763 APX A 11 Apo-Atenidone 100 & 25mg Tab 02248764 APX A 11 Apo-Brimmonidine P 0.15% Oph Sol 02301334 APX B 2 Apo-Gabapentin 600mg Tab 02293358 APX A 14 Apo-Gabapentin 800mg Tab 02293366 APX A 14 Apo-Gliclazide MR 30mg SR Tab 02297795 APX A 4 Apo-Ketorolac 10mg Tab 02229080 APX B 7 Apo-Lisinopril/HCTZ 20/25mg Tab 02261995 APX A 14 Apo-Salvent Ipravent Sterules 500mcg/2.5mg/2.5mL Inh Sol-2.5mL Pk 02266393 APX A 10 Apo-Valacyclovir 500mg Tab 02295822 APX A 5 Artane 0.4mg/mL O/L 00014656 LED A 16 Atripla 600mg/300mg/200mg Tab 02300699 BQU A 9 Betaseron 9,600,000IU Inj Pref Syr-0.3mg Pk 02169649 BAH A 8 Botox 100U/Vial Pd Inj-100U Vial Pk 01981501 ALL A 11 BRIMONIDINE A 6 B 2 BRIMONIDINE TARTRATE & TIMOLOL MALEATE A 2 C.E.S. 1.25mg Tab 00265489 VAL B 5 Cardizem 60mg Tab 02097389 BIO B 5 CEFTRIAXONE DISODIUM A 5 A 14 Ceftriaxone for Injection USP 0.25g/Vial Inj Pd-1 Vial Pk 02292866 ORC A 5 Ceftriaxone for Injection USP 10g/Vial Inj Pd-1 Vial Pk 02292904 APX A 14 CITALOPRAM HYDROBROMIDE A 5 B 2 Citalopram-Odan 20mg Tab 02306239 ODN B 2 Citalopram-Odan 40mg Tab 02306247 ODN B 2 CLARITHROMYCIN A 7 A 14 Clavulin 250mg & 125mg Tab 01916866 GSK A 13 Co Pantoprazole 40mg Ent Tab 02300486 COB A 3 Combigan 0.2% & 0.5% Oph Sol-10mL Pk 09857298 ALL A 2 Cortenema 100mg/60mL Enema-60mL Pk 02112736 BFI A 11 Decadron 0.1% Oph/Ot Sol 00016217 MSD A 16 Diamicron MR 30mg SR Tab 02242987 SEV B 6 DICLOFENAC SODIUM B 3 EFAVIRENZ/TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE A 9 Feldene 10mg Sup 00632708 PFI A 16 Freestyle Lite Blood Glucose Strip 09857297 ABB A 18 GABAPENTIN A 14 Gen-Lisinopril HCTZ 20/25mg Tab 02297752 GEN A 14 Page 8

PRODUCT, STRENGTH & DOSAGE FORM DIN MFR UPDATE PAGE NO. Gen-Pantoprazole 40mg Ent Tab 02299585 GEN A 3 Gen-Ramipril Cap 1.25mg 02301148 GEN A 5 Gen-Ramipril Cap 2.5mg 02301156 GEN A 5 Gen-Ramipril Cap 5mg 02301164 GEN A 5 Gen-Ramipril Cap 10mg 02301172 GEN A 5 Gen-Venlafaxine XR 37.5 mg ER Cap 02310279 GEN A 5 Gen-Venlafaxine XR 75 mg ER Cap 02310287 GEN A 5 Gen-Venlafaxine XR 150 mg ER Cap 02310295 GEN A 5 GLICLAZIDE A 4 Humalog 100U/mL Inj Sol 5x3mL Pk 09853715 LIL A 17 Humalog 100U/mL Inj Sol 10mL Pk 02229704 LIL A 17 Humalog Mix25 25% & 75% Inj Susp-5x3mL Pk 02240294 LIL A 17 Humalog Mix50 50% & 50% Inj Susp-5x3mL Pk 02240297 LIL A 2 INSULIN LISPRO & INSULIN LISPRO PROTAMINE A 2 INTERFERON BETA-1B A 8 ISOSORBIDE-5-MONONITRATE A 14 Kaletra 133.3mg/33.3mg Cap 02243643 ABB A 10 Kaletra 80mg/mL & 20mg/mL O/L 02243644 ABB B 6 Kaletra 200mg & 50mg Tab 02285533 ABB B 6 Kenalog-Orabase Oral Top Oint 01999788 BQU A 10 KETOROLAC TROMETHAMINE B 7 LISINOPRIL & HYDROCHLOROTHIAZIDE A 14 M.O.S. 5mg/mL O/L 00514217 VAL B 5 Mint-Citalopram 20mg Tab 02304686 MIN A 5 Mint-Citalopram 40mg Tab 02304694 MIN A 5 Morphine Sulfate Injection USP 15mg/mL Inj Sol Amp 00850330 HOS A 12 Norpramin 25mg Tab 02099128 SAV A 13 Norpramin 50mg Tab 02099136 SAV A 13 Novo-Citalopram 20mg Tab 02251558 NOP A 15 Novo-Lisinopril/HCTZ (Type P) 20/25mg Tab 02302152 NOP A 14 Novo-Lisinopril/HCTZ (Type Z) 20/25mg Tab 02301784 NOP A 14 Novo-Oxycodone Acet 5mg & 325mg Tab 02307898 NOP B 2 Novo-Pantoprazole 20mg Ent Tab 02285479 NOP A 14 Novolin ge 10/90 Penfill 100U/mL Inj Susp-5x3mL Pk 02024292 NOO A 10 Novolin ge 20/80 Penfill 100U/mL Inj Susp-5x3mL Pk 02024306 NOO A 10 Novolin ge 30/70 1000U/mL Inj Susp-10mL Pk 02024217 NOO A 11 Novolin ge 30/70 Penfill 100U/mL Inj Susp-5x3mL Pk 09853812 NOO A 11 Novolin ge 40/60 Penfill 100U/mL Inj Susp-5x3mL Pk 02024314 NOO A 11 Novolin ge 50/50 Penfill 100U/mL Inj Susp-5x3mL Pk 02024322 NOO A 11 Novolin ge NPH 1000U/10mL Inj Susp-10mL Pk 02024225 NOO A 11 Novolin ge NPH Penfill 100U/mL Inj Susp-5x3mL Pk 09853782 NOO A 11 Novolin ge Toronto 1000U/mL Inj Susp-10mL Pk 02024233 NOO A 11 Novolin ge Toronto Penfill 100U/mL Inj Susp-5x3mL Pk 09853774 NOO A 11 NovoMix 30 Penfill 100U/mL Inj Susp-5x3mL Pk 02265435 NOO A 11 NovoRapid 100U/mL Inj Susp-10mL Pk 02245397 NOO A 11 NovoRapid Penfill 100U/mL Inj Susp-5x3mL Pk 02244353 NOO A 11 Nozinan 5mg Tab 01927655 SAV A 13 Nozinan 25mg Tab 01927663 SAV A 13 Nozinan 50mg Tab 01927671 SAV A 13 Page 9

PRODUCT, STRENGTH & DOSAGE FORM DIN MFR UPDATE PAGE NO. Nutren 2.0 2kcal/mL Liq-250mL Pk 97984701 NES A 10 Nutren Fibre 1kcal/mL Liq-250mL Pk 97984728 NES A 10 Nutren VHP 1kcal/mL Liq-1500mL Pk 09857608 NES A 10 Nutren VHP Fibre 1kcal/mL Liq-250mL Pk 09857516 NES A 10 Nutren VHP Fibre 1kcal/mL Liq-1500mL Pk 09857524 NES A 10 ONDANSETRON HYDROCHLORIDE B 3 Ondansetron-Odan 4mg Tab 02306212 ODN B 3 Ondansetron-Odan 8mg Tab 02306220 ODN B 3 Ortho-Cept 0.15mg & 0.03mg Tab-21 Pk 02042541 JNO A 15 OXYCODONE HCL B 7 OXYCODONE HCL & ACETAMINOPHEN B 2 Oxyderm 20% Lot 00374318 VAL A 10 Panoxyl 15% Gel 00403571 STI A 15 PANTOPRAZOLE SODIUM A 3 A 14 Parlodel 2.5mg Tab 00371033 NOV A 13 PAROXETINE HCL A 14 B 3 Pediatric Peptinex Dt 1kcal/mL Liq-250mL Pk 09857100 NON A 10 Peptinex 1kcal/mL Liq-237mL Pk 09853200 NON A 10 Peptinex DT 1kcal/mL Liq-250mL Pk 09857133 NON A 10 Peptinex DT 1kcal/mL Liq-1500mL Pk 09857125 NON A 10 PMS-Diclofenac 25mg Ent Tab 02302616 PMS B 3 PMS-Diclofenac 50mg Ent Tab 02302624 PMS B 3 PMS-ISMN 60mg ER Tab 02301288 PMS A 14 PMS-Pantoprazole 40mg Ent Tab 02307871 PMS A 3 PMS-Rabeprazole EC 10mg Tab 02310805 PMS A 5 PMS-Rabeprazole EC 20mg Tab 02310813 PMS A 5 PMS-Valacyclovir 500mg Tab 02298457 PMS A 6 RABEPRAZOLE SODIUM A 5 B 4 RAMIPRIL A 5 Ramipril Cap 1.25mg 02299372 RIA A 6 Ramipril Cap 2.5mg 02255316 RIA A 6 Ramipril Cap 5mg 02255324 RIA A 6 Ramipril Cap 10mg 02255332 RIA A 6 Ratio-Pantoprazole 20mg Ent Tab 02308681 RPH A 14 Ratio-Pantoprazole 40mg Ent Tab 02308703 RPH A 3 Rhodis-EC 100mg Ent Tab 00761680 SAV A 13 Rhotrimine 75mg Cap 00761656 SAV A 13 Rhotrimine 100mg Tab 00761648 SAV A 13 Resource Just For Kids Liq-235mL Pk 09853669 NON A 10 Resource Just For Kids with Fibre 1kcal/mL Liq-237mL Pk 09857609 NON A 10 Risperdal Consta 25mg Pd for Inj-Vial Pk 02255707 JNO A 2 Risperdal Consta 37.5mg Pd for Inj-Vial Pk 02255723 JNO A 2 Risperdal Consta 50mg Pd for Inj-Vial Pk 02255758 JNO A 2 RISPERIDONE A 2 A 7 Salofalk 500mg Ent Tab 02112787 BFI A 11 Page 10

PRODUCT, STRENGTH & DOSAGE FORM DIN MFR UPDATE PAGE NO. Sandoz Brimonidine 0.2% Oph Sol 02305429 SDZ A 6 Sandoz Clarithromycin 250mg Tab 02266539 SDZ A 7 Sandoz Clarithromycin 500mg Tab 02266547 SDZ A 14 Sandoz Pantoprazole 40mg Ent Tab 02301083 SDZ A 3 Sandoz Paroxetine 10mg Tab 02269422 SDZ A 14 Sandoz Paroxetine 20mg Tab 02269430 SDZ B 3 02254751 SDZ B 5 Sandoz Paroxetine 30mg Tab 02269449 SDZ B 3 02254778 SDZ B 5 Sandoz Rabeprazole 10mg Tab 02314177 SDZ B 4 Sandoz Rabeprazole 20mg Tab 02314185 SDZ B 4 Sandoz Risperidone 0.25mg Tab 02303655 SDZ A 7 02292807 SDZ A 10 Sandoz Risperidone 0.5mg Tab 02303663 SDZ A 7 02279495 SDZ A 10 Sandoz Venlafaxine XR 37.5mg ER Cap 02310317 SDZ A 7 Sandoz Venlafaxine XR 75mg ER Cap 02310325 SDZ A 7 Sandoz Venlafaxine XR 150mg ER Cap 02310333 SDZ A 7 Sulcrate 1g Tab 02100622 BFI A 11 Sulcrate Suspension Plus 1g/5mL Oral Susp 02103567 BFI A 11 Supeudol 20mg Tab 02262983 SDZ B 7 Terazol 3 80mg Vag Ovule 00894710 JNO B 5 Tofranil 25mg Tab 00010472 NOV A 13 Urso 250mg Tab 02238984 BFI A 11 Urso DS 500mg Tab 02245894 BFI A 11 Vagifem 25mcg Vag Tab 02241332 NOO A 11 VALACYCLOVIR A 5 VENLAFAXINE HCL A 5 Viokase 8000 & 30000 & 30000 USP Units Tab 02230019 BFI A 11 Viokase 16800 & 70000 & 70000 USP U/0.7g Pd-114g Pk 02230020 BFI A 11 Viokase 16 16mg Tab 02241933 BFI A 11 Vitamin B6-ICN 25mg Tab 00268607 VAL B 5 Zantac 150mg Tab 02212331 GSK B 6 Zantac 300mg Tab 02212358 GSK B 6 Page 11